Proprotein convertase subtilisin kexin 9 (PCSK9) and lipoprotein metabolism in relation to adverse birth outcome and future cardiometabolic risk

Singh P.¹ , Singh R.B. ² , Fedacko J.³ , Shehab A.⁴ , Singh V.K.⁵ , Najeeb-Elkilany G.⁶ , Shastun S. ⁷

World Heart Journal

3

Английский

225-229

Опубликовано

Внешняя ссылка

8

2016

• ¹ Department of Obstretics and Gynaecology, Teerthankar Medical College, Moradabad, India
• ² Department of Medicine and Cardiology, Halberg Hospital and Research Institute, Moradabad, India
• ³ Department of Medicine, PJ Safaric University, Kosice, Slovakia
• ⁴ UAE University, United Arab Emirates
• ⁵ Teerthanker Mahaveer Medical College, TMU, Moradabad, India
• ⁶ Department of Cardiology, Gulf Medical College, Ajnam, United Arab Emirates
• ⁷ Department of Normal Physiology, People’s Friendship University of Russia, Moscow, Russian Federation

proprotein convertase 9; alcohol consumption; cardiometabolic risk; cardiovascular disease; diabetes mellitus; Editorial; human; hypercholesterolemia; intrauterine growth retardation; lipoprotein metabolism; low birth weight; middle income country; nutritional deficiency; pregnancy outcome; pregnant woman; protein function; supplementation; tobacco

19.10.2018

19.10.2018

https://repository.rudn.ru/ru/records/article/record/4428/